MARIN BIOTECH AS
Operating
Valorisering av marint restråstoff til produkter med høy verdi. De nye
produktene kan brukes i fôr til akvakultur, i fôr til kjæledyr, til
humant konsum eller kosmetisk industri. Det er et bioteknologiselskap
med høyt fokus på forskning og utvikling.
Forskning og utviklingsarbeid innen bioteknologi.
Organization
- CEO
- VD
- Chairman of the board
- VD
- Years since formation
- 1 year
- since Feb 28, 2025
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Financials
- Annual total result 2025
- -57,023
- NOK
- Total equity 2025
- -27,023
- NOK
Last update: May 20, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
VD | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
VD | Chairman | - |
OP | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Last update: Feb 10, 2026
Ownership
No available data
Financials
in NOK
Summary
| Year | 2025 |
|---|---|
Total operating income | 0 |
Annual Total Result | -57,023 |
Total assets | 228,177 |
Total liabilities | 255,201 |
Total equity | -27,023 |
P&L
| Year | 2025 |
|---|---|
Total operating income | 0 |
Total operating costs | 73,107 |
Operating result | -73,107 |
Financial income/costs | 0 |
Profit before tax | -73,107 |
Total tax & extraordinary income/cost | -16,084 |
Annual Total Result | -57,023 |
Balance overview
| Year | 2025 |
|---|---|
Total fixed assets | 58,164 |
Total current assets | 170,013 |
Total assets | 228,177 |
Short term debt | 255,201 |
Long term debt | 0 |
Total liabilities | 255,201 |
Contributed capital | 30,000 |
Retained earnings | -57,023 |
Total equity | -27,023 |
Total equity and liabilities | 228,177 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises